Skip to content

Effect of High Flow Nasal During Exercise in COPD Patients

Acute Effects of High Flow Nasal Support During Exercise in Patients With COPD After Severe Exacerbation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03058081
Acronym
AiRehab
Enrollment
19
Registered
2017-02-20
Start date
2017-08-01
Completion date
2018-06-18
Last updated
2018-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD Exacerbation

Keywords

COPD, Exercise, High Flow Nasal, Muscle Oxygenation, Pulmonary Rehabilitation

Brief summary

Early pulmonary rehabilitation is recommended after an episode of severe exacerbation of chronic obstructive pulmonary disease (COPD). However, its implementation is challenging particularly as regard exercise training. High flow ventilation in reducing work of breathing and dyspnea may improve exercise tolerance. The aim of this study is to carry out the acute effect of high flow nasal cannula on exercise endurance in post-exacerbation copd patients

Interventions

DEVICEHigh Flow nasal cannula

High intensity Constant Work-Rate exercise test with High Flow Nasal Cannula in COPD patients involved in a Pulmonary Rehabilitation Program after an exacerbation (\< 7 days after hospital discharge). High Flow nasal will be administered through nasal cannula using the Airvo2 (Fisher&Paykel)

Sponsors

Groupe Hospitalier du Havre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* a diagnosis of COPD

Exclusion criteria

* exercise contraindication Any musculoskeletal problems, cardiovascular or neurological comorbidities that limits exercise. * pH \< 7,35 * Body temperature \> 38°C * cardiac frequency \> 100 bpm at rest * systolic blood pressure \< 100 mmHg * exacerbation during the study

Design outcomes

Primary

MeasureTime frameDescription
Difference in exercise capacityThe outcome will be measure after every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 3 days maximumDifference in endurance time (TLim) during High Intensity Constant Work-Rate Endurence Test (CWRET)

Secondary

MeasureTime frameDescription
Difference in Dyspnea and muscular fatigueThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 3 days maximum. Data will be collected every 2 minute during tests and at the end of the exerciseDifference in dyspnea and muscular fatigue using Modified Borg Scale (0 - 10 points)
Difference in Oxygen SaturationThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 3 days maximum. Data will be continuously collected during exerciseDifference in Oxygen Saturation using a pulse oximetry (SpO2)
Difference in Cardiac FrequencyThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 3 days maximum. Data will be continuously collected during exerciseDifference in Cardiac Frequence using a pulse oximetry
Difference in peripheral muscle oxygenationThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 3 days maximum. Data will be continuously collected during exerciseMuscle oxygenation will be evaluated using Near-infrared spectroscopy technology.
Difference in Respiratory RateThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 3 days maximum. Data will be continuously collected during exerciseDifference in Respiratory Rate using a Respiratory Inductive Plethysmography
Difference in Respiratory Muscle FatigueThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 3 days maximum. Data will be collected before and 5 minute maximum after exerciseDifference in Respiratory Muscle Fatigue using an electronical manometer
Difference in Transcutaneous Carbon DioxideThe outcome will be measure during every CWRET. The two CWRET will be carried out in different days, separate from 24H minimum for a total time frame of 3 days maximum. Data will be continuously collected during exerciseDifference Transcutaneous Carbon Dioxide using Transcutaneous Carbon Dioxide using a Transcutaneous capnography

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026